CVET

Covetrus, Inc. [CVET] Stock Forecast

Q: What is Covetrus, Inc. stock symbol ?

Covetrus, Inc. is a US stock, located in Portland of Maine and trading under the symbol CVET

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CVET Stock Summary

Earnings have grown 5.44% per last year.

Earnings are expected to rise 16.37% next year

Currently unprofitable, and not expected to turn profitable in the coming year

CVET has less than 1 year of cash runway

Debt-to-Equity ratio of 1.24 is considered moderate, deeper research suggested.

In the News

09:51 29 Sep 2023 CVET

CD&R, TPG Take Covetrus Private In $4B Deal

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates.

08:49 29 Sep 2023 CVET

Covetrus going private in $4 billion deal

Animal health company Covetrus Inc. CVET, -0.20% said Wednesday it agreed to be taken private by Clayton, Dubilier & Rice (CD&R) and TPG Capital TPG, -0.90% in a deal valued at $4 billion. The two private equity firms agreed to pay $21 a share, which is $1.34 or 6.8% over its closing price of $19.66 a share on Tuesday and a 39% premium over its 30-day volume weighted average price per share as of the unaffected stock price as of May 13.

08:44 29 Sep 2023 CVET

Covetrus to Be Taken Private for $4 Billion

Private-equity firms CD&R and TPG Capital will pay $21 a share to acquire the veterinary services company.

08:29 29 Sep 2023 CVET

Covetrus Gets Private-Equity Buyout Offer at $21 a Share

CD&R and TPG offer to pay $21 a share in cash for Covetrus, which develops technologies and services for the animal health industry.

08:19 29 Sep 2023 CVET

Covetrus (CVET) Q1 Earnings Surpass Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 8.70% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

11:22 29 Sep 2023 CVET

Covetrus, Inc. (CVET) CEO Ben Wolin on Q4 2021 Results - Earnings Call Transcript

08:00 29 Sep 2023 CVET

Covetrus (CVET) Q4 Earnings Surpass Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 4% and 1.40%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

07:04 29 Sep 2023 CVET

Covetrus (CVET) Matches Q3 Earnings Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 0.00% and -0.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

04:31 29 Sep 2023 CVET

Covetrus: Q3 Earnings Insights

Covetrus (NASDAQ:CVET) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

08:30 29 Sep 2023 CVET

Covetrus Announces Third Quarter 2021 Earnings Release Date and Conference Call Information

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus will release Q3 2021 results after the market close on Thursday, November 4, 2021 and the company will hold a conference call at 4:30 PM ET.

CVET Financial details

Company Rating

Buy

Market Cap

Income

-13M

Revenue

4.65B

Book val./share

10.75

Cash/share

0.62

Dividend

Dividend %

Employees

4.04K

Optionable

Shortable

Yes

Earnings

02 Nov 2022

P/E

-489.77

Forward P/E

PEG

118.73

P/S

P/B

1.95

P/C

P/FCF

Quick Ratio

1.01

Current Ratio

1.88

Debt / Equity

1.24

LT Debt / Equity

0.65

EPS (TTM)

-0.09

EPS next Y

EPS next Q

0.24

EPS this Y

293.75%

EPS next Y

EPS next 5Y

-1115.96%

EPS last 5Y

NAN%

Revenue last 5Y

5.03%

Revenue Q/Q

6.01%

EPS Q/Q

97.24%

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

ROE

ROC

Gross Margin

19%

Oper. Margin

Profit Margin

Payout

Shs Outstand

140.12M

Shs Float

105.28M

Target Price

52W Range

13.39-21.2

52W High

52W Low

RSI

Rel Volume

4.36

Avg Volume

1.22M

Volume

Perf Week

Perf Month

Perf Quarter

Perf Half Y

Beta

1.50574

Volatility

9.89%, 9.89%

Prev Close

Price

Change

CVET Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31
Revenue per share	32.19	33.98	37.16	36.77	33.39
Net income per share	0.58	0.91	-9.52	-0.16	-0.39
Operating cash flow per share	0.97	1.42	0.96	0.45	0.74
Free cash flow per share	0.79	1.22	0.6	-0.04	0.31
Cash per share	0.15	0.21	1.21	2.46	1.34
Book value per share	10.91	13.43	11.74	13.03	11.03
Tangible book value per share	2.24	4.82	-5.06	-1.74	-1.28
Share holders equity per share	10.91	13.43	11.74	13.03	11.03
Interest debt per share	0.24	0.22	11.62	9.46	7.87
Market cap	4.67B	4.67B	1.41B	3.39B	2.74B
Enterprise value	4.68B	4.67B	2.47B	4.17B	3.6B
P/E ratio	72.57	46.3	-1.39	-178.49	-50.66
Price to sales ratio	1.3	1.24	0.36	0.78	0.6
POCF ratio	43.17	29.58	13.71	63.99	26.82
PFCF ratio	53.36	34.37	22.07	-678.26	65.14
P/B Ratio	3.85	3.13	1.12	2.21	1.81
PTB ratio	3.85	3.13	1.12	2.21	1.81
EV to sales	1.31	1.24	0.62	0.96	0.79
Enterprise value over EBITDA	27.3	23.12	-3.11	19.76	20.22
EV to operating cash flow	43.26	29.58	23.97	78.69	35.28
EV to free cash flow	53.47	34.38	38.58	-834.06	85.69
Earnings yield	0.01	0.02	-0.72	-0.01	-0.02
Free cash flow yield	0.02	0.03	0.05	0	0.02
Debt to equity	0.79	0.5	1.68	1.27	1.26
Debt to assets	0.44	0.33	0.63	0.56	0.56
Net debt to EBITDA	0.06	0	-1.33	3.69	4.85
Current ratio	2.11	1.9	1.62	2.07	1.94
Interest coverage	0	0	-17.8	-1.47	-0.72
Income quality	1.68	1.57	-0.1	-2.79	-1.89
Dividend Yield	0	0	0.83	0	0
Payout ratio	0	0	-1.15	-0.32	0
Sales general and administrative to revenue	0.14	0.14	0.2	0.2	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.44	0.43	0.53	0.5	0.49
Capex to operating cash flow	-0.19	-0.14	-0.38	-1.09	-0.59
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-0.35	-0.34	-0.22	-0.31	-0.3
Stock based compensation to revenue	0	0	0.01	0.01	0.01
Graham number	11.92	16.56	50.15	6.87	9.89
ROIC	0.05	0.06	-0.38	-0.02	-0.01
Return on tangible assets	0.05	0.08	-0.65	-0.01	-0.03
Graham Net	-2.64	-0.67	-12.03	-8.25	-7.36
Working capital	565.34M	514.04M	511M	740M	653M
Tangible asset value	249.3M	535.64M	-541M	-205M	-175M
Net current asset value	121.9M	347.14M	-765M	-528M	-548M
Invested capital	0.02	0.02	0.95	0.7	0.69
Average receivables	463.6M	491.76M	486.5M	533.5M	564.5M
Average payables	358.48M	408.62M	480.73M	462.5M	423.5M
Average inventory	504.16M	549.41M	600.08M	583M	556.5M
Days sales outstanding	51.34	46.37	45.26	48.29	44.28
Days payables outstanding	46.85	52.08	58.82	41.75	43.4
Days of inventory on hand	66.66	66.56	71.94	54.63	57.25
Receivables turnover	7.11	7.87	8.06	7.56	8.24
Payables turnover	7.79	7.01	6.21	8.74	8.41
Inventory turnover	5.48	5.48	5.07	6.68	6.38
ROE	0.05	0.07	-0.81	-0.01	-0.04
Capex per share	-0.19	-0.2	-0.36	-0.49	-0.44

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric	2021-06-30	2021-09-30	2021-12-31	2022-03-31	2022-06-30
Revenue per share	8.68	8.48	8.13	8.32	8.69
Net income per share	-0.23	-0.03	-0.02	-0.01	-0.03
Operating cash flow per share	0.42	0.43	0.32	-0.24	-0.04
Free cash flow per share	0.34	0.33	0.16	-0.32	-0.15
Cash per share	1.68	1.36	1.33	0.85	0.62
Book value per share	10.96	10.96	10.95	11.07	10.75
Tangible book value per share	-1.23	-1.64	-1.27	-0.95	-0.86
Share holders equity per share	10.96	10.96	10.95	11.07	10.75
Interest debt per share	7.88	7.89	7.62	7.64	7.54
Market cap	3.7B	2.49B	2.76B	2.32B	2.91B
Enterprise value	4.54B	3.37B	3.62B	3.25B	3.87B
P/E ratio	-29.83	-155.32	-229.66	-289.63	-181.56
Price to sales ratio	3.11	2.14	2.46	2.02	2.39
POCF ratio	63.78	42.12	62.63	-70.21	-484.17
PFCF ratio	78.7	55.23	125.27	-52.66	-138.33
P/B Ratio	2.46	1.65	1.82	1.52	1.93
PTB ratio	2.46	1.65	1.82	1.52	1.93
EV to sales	3.82	2.9	3.23	2.83	3.18
Enterprise value over EBITDA	100.89	78.4	77	57.98	74.37
EV to operating cash flow	78.28	57.14	82.25	-98.39	-644.5
EV to free cash flow	96.6	74.92	164.49	-73.8	-184.14
Earnings yield	-0.01	0	0	0	0
Free cash flow yield	0.01	0.02	0.01	-0.02	-0.01
Debt to equity	1.27	1.28	1.26	1.26	1.24
Debt to assets	0.56	0.56	0.56	0.55	0.55
Net debt to EBITDA	18.69	20.6	18.36	16.61	18.5
Current ratio	2	1.89	1.94	1.86	1.88
Interest coverage	-1	-0.5	-1.17	0.86	0.57
Income quality	-1.87	-14.75	-14.67	16.5	1.5
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.49	0.5	0.49	0.48	0.48
Capex to operating cash flow	-0.19	-0.24	-0.5	0.33	2.5
Capex to revenue	-0.01	-0.01	-0.02	-0.01	-0.01
Capex to depreciation	-0.2	-0.29	-0.43	-0.23	-0.31
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	7.47	2.68	2.31	1.9	2.63
ROIC	-0.01	0	0	0	0
Return on tangible assets	-0.02	0	0	0	0
Graham Net	-6.98	-7.51	-7.31	-7.38	-7.13
Working capital	710M	637M	653M	655M	645M
Tangible asset value	-169M	-224M	-175M	-131M	-121M
Net current asset value	-493M	-567M	-548M	-503M	-493M
Invested capital	0.71	0.71	0.69	0.69	0.7
Average receivables	600.5M	582M	561.5M	591M	641.5M
Average payables	421.5M	427.5M	435M	474.5M	476.5M
Average inventory	556M	554.5M	567.5M	606.5M	608.5M
Days sales outstanding	45.11	43.99	44.52	49.16	48.51
Days payables outstanding	39.66	40.72	43.71	49.44	40.63
Days of inventory on hand	51.73	52.52	57.66	61.43	53.47
Receivables turnover	1.99	2.05	2.02	1.83	1.86
Payables turnover	2.27	2.21	2.06	1.82	2.22
Inventory turnover	1.74	1.71	1.56	1.47	1.68
ROE	-0.02	0	0	0	0
Capex per share	-0.08	-0.1	-0.16	-0.08	-0.11

CVET Frequently Asked Questions

What is Covetrus, Inc. stock symbol ?

Covetrus, Inc. is a US stock , located in Portland of Maine and trading under the symbol CVET

What is Covetrus, Inc. stock quote today ?

Covetrus, Inc. stock price is $- today.

Is Covetrus, Inc. stock public?

Yes, Covetrus, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Company Profile

Volume Average 1.22M
Employee 4.04K
CEO Mr. Benjamin Wolin
Headquarters Portland,MAINE,US
IPO Date 2019-02-04
Website https://www.covetrus.com

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.